Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.058 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |